Company: DVAX
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001628280-25-049536
Chunk: 294

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 8
Chunk 294
---
 of shares of common stock reserved under the 2021 Inducement Plan to 3,250,000. The Amended 2021 Inducement Plan was terminated effective as of April 3, 2022 and, therefore, there are no shares of our common stock available for grant.In May 2024, our stockholders approved the amendment and restatement of our 2018 Equity Incentive Plan (the “Amended 2018 EIP”) to, among other things, increase the authorized number of shares of common stock by 11,400,000. The maximum number of shares of common stock that may be issued under the Amended 2018 EIP will not exceed 41,440,250 shares of common stock. As of September 30, 2025, the Amended 2018 EIP and the Amended and Restated 2014 Employee Stock Purchase Plan are our active plans.The Amended 2018 EIP is administered by our Board of Directors, or a designated committee of the Board of Directors, and awards granted under the Amended 2018 EIP have a term of seven years unless earlier terminated by the Board of Directors. As of September 30, 2025, there were 8,583,472 shares of common stock reserved for issuance under the Amended 2018 EIP.Under our Amended 2018 EIP, we may grant stock options, restricted stock units (“RSUs”), performance-based awards, and other awards that are settled in shares of our common stock. Our equity awards generally vest over a three-year period contingent upon continuous service and unless exercised, expire seven or ten years from the date of grant (or earlier upon termination of continuous service). Activity under the Amended 2018 EIP is set forth below:

23

Stock Options The following table summarizes the activity of stock options for the nine months ended September 30, 2025: SharesUnderlyingOutstandingOptions(in thousands)Weighted-AverageExercisePrice Per ShareWeighted-AverageRemainingContractualTerm (years)AggregateIntrinsicValue (in thousands)Balance as of December 31, 202411,142$11.15 3.79$24,210 Options granted1,81912.41 Options exercised(734)9.29 Options cancelled:Options forfeited (unvested)(131)12.33 Options expired (vested)(975)16.39 Balance as of September 30,